Overview

Study to Evaluate ctDNA of mCSPC Patients Receiving Apalutamide in Japan

Status:
Recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
To evaluate changes in genomic alterations for 73 PC driver genes during apalutamide treatment
Phase:
Phase 4
Details
Lead Sponsor:
Kindai University
Collaborator:
Janssen Pharmaceutical K.K.